Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00434369
Status:
UNKNOWN
Last Update Posted:
2008-04-22
First Post:
2007-02-07
Brief Title:
5-Fluorouracil Combined With CoFactor 5-10 Methylenetetrahydrofolate in Treating Advanced Breast Cancer Patients
Sponsor:
Mast Therapeutics Inc
Organization:
Mast Therapeutics Inc
Study Overview
Official Title:
A Multi-Center Open-Label Single-Arm Phase II Trial Assessing the Efficacy and Safety of Weekly Bolus Infusions of 5-Fluorouracil Combined With CoFactor 5-10 Methylenetetrahydrofolate in Advanced Breast Cancer Patients Who Failed Anthracycline and Taxane Chemotherapy Regimens
Status:
UNKNOWN
Status Verified Date:
2008-04
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A multi-center open-label single-arm Phase II trial assessing the efficacy and safety of weekly bolus infusions of 5-fluorouracil combined with CoFactor 5-10 methylenetetrahydrofolate in advanced breast cancer patients who failed anthracycline and taxane chemotherapy regimens
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None